Advisor Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $3.31M | Sell |
36,856
-9,578
| -21% | -$970K | 0.23% | 82 |
|
|
2022
Q1 | $5.15M | Sell |
46,434
-2,346
| -5% | -$248K | 0.32% | 56 |
|
|
2021
Q4 | $5.05M | Sell |
48,780
-6,501
| -12% | -$753K | 0.3% | 58 |
|
|
2021
Q3 | $6.93M | Sell |
55,281
-2,815
| -5% | -$364K | 0.47% | 40 |
|
|
2021
Q2 | $7.21M | Sell |
58,096
-8
| -0% | -$1K | 0.47% | 41 |
|
|
2021
Q1 | $6.86M | Sell |
58,104
-243
| -0.4% | -$28.5K | 0.49% | 42 |
|
|
2020
Q4 | $6.83M | Buy |
58,347
+1,904
| +3% | +$210K | 0.51% | 39 |
|
|
2020
Q3 | $5.87M | Buy |
56,443
+2,279
| +4% | +$229K | 0.5% | 43 |
|
|
2020
Q2 | $4.97M | Buy |
54,164
+6,083
| +13% | +$583K | 0.46% | 47 |
|
|
2020
Q1 | $4.34M | Buy |
48,081
+6,578
| +16% | +$700K | 0.52% | 43 |
|
|
2019
Q4 | $4.87M | Buy |
41,503
+10,991
| +36% | +$1.21M | 0.5% | 46 |
|
|
2019
Q3 | $3.31M | Buy |
30,512
+3,329
| +12% | +$347K | 0.4% | 51 |
|
|
2019
Q2 | $2.65M | Sell |
27,183
-410
| -1% | -$37.4K | 0.32% | 61 |
|
|
2019
Q1 | $2.51M | Sell |
27,593
-677
| -2% | -$60.6K | 0.32% | 63 |
|
|
2018
Q4 | $2.57M | Buy |
28,270
+6,071
| +27% | +$567K | 0.41% | 55 |
|
|
2018
Q3 | $2.18M | Buy |
22,199
+1,753
| +9% | +$162K | 0.29% | 67 |
|
|
2018
Q2 | $1.75M | Buy |
20,446
+3,014
| +17% | +$252K | 0.3% | 72 |
|
|
2018
Q1 | $1.4M | Buy |
17,432
+1,102
| +7% | +$90.9K | 0.26% | 80 |
|
|
2017
Q4 | $1.42M | Buy |
16,330
+1,731
| +12% | +$139K | 0.25% | 89 |
|
|
2017
Q3 | $1.14M | Sell |
14,599
-815
| -5% | -$67.7K | 0.22% | 98 |
|
|
2017
Q2 | $1.37M | Buy |
15,414
+2,302
| +18% | +$194K | 0.32% | 76 |
|
|
2017
Q1 | $1.06M | Buy |
13,112
+2,897
| +28% | +$226K | 0.28% | 88 |
|
|
2016
Q4 | $728K | Sell |
10,215
-3,643
| -26% | -$286K | 0.22% | 117 |
|
|
2016
Q3 | $1.2M | Buy |
13,858
+471
| +4% | +$41K | 0.4% | 63 |
|
|
2016
Q2 | $1.16M | Buy |
13,387
+914
| +7% | +$73.9K | 0.41% | 65 |
|
|
2016
Q1 | $935K | Sell |
12,473
-1,712
| -12% | -$129K | 0.35% | 81 |
|
|
2015
Q4 | $1.09M | Buy |
14,185
+8,499
| +149% | +$640K | 0.37% | 78 |
|
|
2015
Q3 | $381K | Sell |
5,686
-16,373
| -74% | -$1.21M | 0.16% | 165 |
|
|
2015
Q2 | $1.7M | Buy |
22,059
+2,108
| +11% | +$161K | 0.65% | 37 |
|
|
2015
Q1 | $1.56M | Buy |
19,951
+6,190
| +45% | +$469K | 0.66% | 37 |
|
|
2014
Q4 | $978K | Buy |
13,761
+4
| +0% | +$278 | 0.43% | 66 |
|
|
2014
Q3 | $852K | Buy |
13,757
+55
| +0.4% | +$3.5K | 0.49% | 58 |
|
|
2014
Q2 | $874K | Buy |
13,702
+147
| +1% | +$8.93K | 0.43% | 63 |
|
|
2014
Q1 | $834K | Buy |
13,555
+334
| +3% | +$19.5K | 0.46% | 61 |
|
|
2013
Q4 | $759K | Buy |
13,221
+747
| +6% | +$42.4K | 0.44% | 67 |
|
|
2013
Q3 | $664K | Buy |
12,474
+758
| +6% | +$40.8K | 0.47% | 67 |
|
|
2013
Q2 | $603K | Buy |
+11,716
| New | +$579K | 0.49% | 64 |
|
Other funds holding MDT
Advisor Partners's MDT Position: Q2 2022 in Review
Advisor Partners reduced its Medtronic (MDT) stake by 21% in Q2 2022, selling an estimated $970K and leaving 36,856 shares worth $3.31M. The position accounts for 0.23% of the portfolio, ranked #82.
Advisor Partners first reported a position in MDT in Q2 2013 and has held it in 37 quarters since. The position peaked at $7.21M in Q2 2021. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.
- Advisor Partners held 36,856 shares of Medtronic worth $3.31M as of Q2 2022.
- Advisor Partners sold 9,578 Medtronic shares in Q2 2022, an estimated $970K.
- Medtronic made up 0.23% of Advisor Partners's portfolio in Q2 2022, its #82 holding.
- Advisor Partners first reported a position in Medtronic in Q2 2013 and has held it in 37 quarters since.
- Advisor Partners's Medtronic position peaked at $7.21M in Q2 2021.
- 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.